КОМБИНИРОВАННЫЕ ОПЕРАЦИИ У ПАЦИЕНТОВ С РЕЗЕКТАБЕЛЬНЫМ РАКОМ ЖЕЛУДКА
https://doi.org/10.29235/1814-6023-2018-15-2-207-214
Анатацыя
Аб аўтарах
М. РевтовичРасія
О. Суконко
Расія
А. Шмак
Расія
О. Красько
Расія
Спіс літаратуры
1. Postoperative results of left upper abdominal evisceration for advanced gastric cancer / Y. Yonemura [et al.] // Hepatogastroenterology. – 2000. – Vol. 47, N 32. – P. 571–574.
2. Improvement of the prognosis of gastric cancer with extensive serosal invasion using left upper abdominal evisceration / H. Isozaki [et al.] // Hepatogastroenterology. – 2001. – Vol. 48, N 40. – P. 1179–1182.
3. Бутенко, А. В. Комбинированные и расширенные операции при раке желудка : дис. … д-ра мед. наук : 14.00.14 / А. В. Бутенко. – М., 1999. – 271 л.
4. Combined resection of invaded organs in patients with T4 gastric carcinoma / H. Saito [et al.] // Gastric Cancer. – 2001. – Vol. 4, N 4. – P. 206–211. DOI: 10.1007/s101200100023
5. Combined resection of the involved organs in T4 gastric cancer / K. Kitamura [et al.] // Hepatogasroenterology. – 2000. – Vol. 47, N 36. – P. 1769–1772.
6. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials / C. J. A. Punt [et al.] // J. of the Nat. Cancer Inst. – 2007. – Vol. 99, N 13. – P. 998–1003. DOI: 10.1093/jnci/ djm024
7. Kalbfleisch, J. D. The Statistical Analysis of Failure Time Data / J. D. Kalbfleisch, R. L. Prentice. – New York : John Wiley and Sons, 1980. – 321 p.
8. Gray, R. J. A class of k-sample tests for comparing the cumulative incidence of a competing risk / R. J. Gray // Annals of Statistics. – 1988. – Vol. 16, N 3. – P. 1141–1154. DOI: 10.1214/aos/1176350951
9. R Core Team (2014). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria [Electronic resource] // The R Project for Statistical Computing. – Mode of access : http://www.R-project.org/. – Date of access : 01.11.2014. 10. Gray, B. cmprsk: Subdistribution Analysis of Competing Risks. R package version 2.2-7 [Electronic resource] / B. Gray // The R Project for Statistical Computing. – Mode of access : http://CRAN.R-project.org/package=cmprsk. – Date of access : 18.08.2017.
10. Five-year survival prognosis factors in patients with resectable advanced serosa exposed gastric carcinoma / E. F. Yan- Quiroz [et al.] // Rev. of Gastroenterology in Peru. – 2003. – Vol. 23, N 3. – P. 184–191.
11. Extended surgical resection in T4 gastric cancer / I. B. Schepotin [et al.] // Amer. J. of Surgery. – 1998. – Vol. 175, N 2. – P. 123–126. DOI: 10.1016/S0002-9610(97)00268-7
12. Morbidity and mortality after total gastrectomy for gastric malignancy using the American College of Surgeons National Surgical Quality Improvement Program database / E. K. Bartlett [et al.] // Surgery. – 2014. – Vol. 156, N 2. – P. 298– 304. DOI: 10.1016/j.surg.2014.03.022
13. Extended multiorgan resection in T4 gastric carcinoma: 25-year experience / F. Carboni [et al.] // J. of Surgical Oncology. – 2005. – Vol. 90, N 2. – P. 95–100. DOI: 10.1002/jso.20244
14. Prognosis of 980 patients with gastric cancer after surgical resection / W. Wang [et al.] // Chinese J. of Cancer. – 2010. – Vol. 29, N 11. – P. 923–930.
15. Number of lymph nodes removed and survival after gastric cancer resection: an analysis from the us gastric cancer collaborative / S. Gholami [et al.] // J. of the Amer. College of Surgeons. – 2015. – Vol. 221, N 2. – P. 291–299. DOI: 10.1016/ j.jamcollsurg.2015.04.024
16. Multimodality Treatment of T4 Gastric Cancer in theUnited States: Utilization Trends and Impact on Survival / L. Lowenfeld [et al.] // Annals of Surgical Oncology. – 2015. – Vol. 22, Suppl. 3. – P. 863–872. DOI: 10.1245/s10434-015-4677-y
17. Adjuvant hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) associated with curative surgery for locally advanced gastric carcinoma. An initial experience / A. de Roover [et al.] // Acta Chirurgica Belgica. – 2006. – Vol. 106, N 3. – P. 297–301.
18. Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion / L.-Y. Kang [et al.] // J. of the Chinese Med. Association. – 2013. – Vol. 76, N 8. – P. 425–431. DOI: 10.1016/j.jcma.2013.04.004
19. Sano, T. For the Gastric Cancer Surgical Study Group of the Japan Clinical Oncology Group (JCOG). Randomized controlled trial to evaluate para-aortic lymphadenectomy for gastric cancer (JCOG 9501) / T. Sano, M. Sasako // 4th International Gastric Cancer Congress, New York, USA, April 30–May 2, 2001 / ed. : M. F. Brennan, M. S. Karpeh. – New York, 2001. – P. 645–663.
20. Aggressive surgical treatment for T4 gastric cancer / A. Kobayashi [et al.] // J. of Gastrointestinal Surgery. – 2004. – Vol. 8, N 4. – P. 464–470. DOI: 10.1016/j.gassur.2003.12.018
21. Рациональное обеспечение комбинированных операций при местнораспространенном раке желудка / Н. Н. Симонов [и др.] // Вестн. хирургии им. Грекова. – 1997. – Т. 156, № 3. – С. 22–25.
##reviewer.review.form##
Для цытавання:
Ревтович М.Ю., Суконко О.Г., Шмак А.И., Красько О.В. КОМБИНИРОВАННЫЕ ОПЕРАЦИИ У ПАЦИЕНТОВ С РЕЗЕКТАБЕЛЬНЫМ РАКОМ ЖЕЛУДКА. Известия Национальной академии наук Беларуси. Серия медицинских наук. 2018;15(2):207-214. https://doi.org/10.29235/1814-6023-2018-15-2-207-214
For citation:
Reutovich M.Yu., Sukonko O.G., Shmak A.I., Krasko V.V. COMBINED OPERATIONS IN PATIENTS WITH RESECTABLE GASTRIC CANCER. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2018;15(2):207-214. (In Russ.) https://doi.org/10.29235/1814-6023-2018-15-2-207-214